Heart failure is the terminal stage of various cardiovascular diseases, usually characterized by pathological myocardial ...

Sustained exposure to pathological stress stimulates the heart to hypertrophy, increasing disease and mortality risk. New therapies to blunt this process include targeting enzymes below the cell ...

Aim Differentiating physiological cardiac hypertrophy from pathology is challenging when the athlete presents with extreme anthropometry. While upper normal limits exist for maximal left ventricular ...

Another active area of research in the laboratory focuses on unraveling the mechanisms behind maladaptive, or pathological, and adaptive, or physiological, cardiac hypertrophy. In response to certain ...

A study reveals that a personalized approach, considering age, sex and size, improves the diagnosis of hypertrophic ...

More information: Xiang Nie et al, lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating ...

Left ventricular hypertrophy (LVH) is an abnormal thickening ... electrical activity takes longer to traverse throughout the whole heart, thus the duration of the QRS complex may be widened.

Right ventricular hypertrophy occurs when the right ventricular wall thickens due to chronic pressure overload, similar to that of left ventricular hypertrophy. RVH is diagnosed on ECG in the ...

The aging right heart Aging imparts known changes to the left heart- including hypertrophy, fibrosis, inflammation, and overall reduced cardiac function. How these changes impact the right heart ...

Persistent smoking from age 10 through 24 years is associated with increased odds of premature cardiac and structural injury.

Background and aims Hypertrophic cardiomyopathy (HCM) has various aetiologies, including genetic conditions like Fabry ...